.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Federal Trade Commission
Chinese Patent Office
McKesson
Queensland Health
Daiichi Sankyo
Boehringer Ingelheim
Express Scripts
Accenture
US Army

Generated: July 27, 2017

DrugPatentWatch Database Preview

TRANSDERM SCOP Drug Profile

« Back to Dashboard

What is the patent landscape for Transderm Scop, and when can generic versions of Transderm Scop launch?

Transderm Scop is a drug marketed by Glaxosmithkline Con and is included in one NDA.

The generic ingredient in TRANSDERM SCOP is scopolamine. There are twenty-one drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the scopolamine profile page.

Summary for Tradename: TRANSDERM SCOP

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Bulk Api Vendors: see list20
Clinical Trials: see list2
Patent Applications: see list6,200
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRANSDERM SCOP at DailyMed

Pharmacology for Tradename: TRANSDERM SCOP

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline Con
TRANSDERM SCOP
scopolamine
FILM, EXTENDED RELEASE;TRANSDERMAL017874-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TRANSDERM SCOP

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Con
TRANSDERM SCOP
scopolamine
FILM, EXTENDED RELEASE;TRANSDERMAL017874-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Glaxosmithkline Con
TRANSDERM SCOP
scopolamine
FILM, EXTENDED RELEASE;TRANSDERMAL017874-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Glaxosmithkline Con
TRANSDERM SCOP
scopolamine
FILM, EXTENDED RELEASE;TRANSDERMAL017874-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Cipla
Chubb
Farmers Insurance
Cantor Fitzgerald
Teva
McKinsey
Harvard Business School
Julphar
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot